| |
| center
|
:
|
Isfahan University of Medical Sciences
|
| Document Type
|
:
|
Latin Dissertation
|
| Language of Document
|
:
|
English
|
| Record Number
|
:
|
102910
|
| Doc. No
|
:
|
T13338
|
| Call number
|
:
|
QZ,380,M935,2012
|
| Main Entry
|
:
|
Movahedipour, Mohammad
|
| Title & Author
|
:
|
An immunohistocal study of HER-2/ neu expression in mennigioma and its correlation with tumor grade/محمد موحدی پور
|
| College
|
:
|
Schools, Medical
|
| Date
|
:
|
, 2012
|
| Degree
|
:
|
Pathology, Speciality
|
| Page No
|
:
|
50 p.: tab
|
| Note
|
:
|
This thesis is also a research project with project- ID 389447
|
| Abstract
|
:
|
Meningiomas account for 15-30 percent of alll primary intracranial tumors. They are divided into three grades, Recurrence is an issue following surgical treatment of meningioma. especially in grads II and III. HER2 is a transmembrane glycoprotein with tyrosine kinase activity and can be a potential target for therapeutic intervention with selective inhibitors. The aim of this study was to determine the relationship between meninigioma and HER2 Expression. Seventy- two paraffin blocks of meningioma were selected randomly, and immunohistochemical staining was then prformed for each specimen. P- value less than 0.05 was considered as significant. Thirty- One of the 72 meningiomas were HERS- positive. Her2 expression was observed in 11 ( 55 percent) of the 20 grade II/III, and 20 ( 38.5 Percent ) of the 52 grade I meningiomas. HER2 expression was detected in 43 Percent of meningiomas, No significant difference was seen between grade I and II / III meningiomas, primary and recurrent tumors, and males and females from the point of veiw of HER2 expression.
|
| Descriptor
|
:
|
1. Meningioma.- Descriptors: Immunohistochemistry
|
|
|
:
|
Meningioma
|
|
|
:
|
Brain Neoplasms
|
|
|
:
|
Antibadies, Monoclonal
|
|
|
:
|
Antibadies, Formation
|
| Added Entry
|
:
|
Mahzoni, Parvin, Supervisor
|
| | | | | |
| | |  |
http://elib.mui.ac.ir/site/catalogue/102910
| | | |
| | | |
|